Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer.

Details

Language :

English

ISSN :

0732183X

Volume :

27

Issue :

19

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

105374903

Full Text :

https://doi.org/10.1200/JCO.2008.20.9114